Priority Research Area Infections

Microbial Interface Biology

Mission   Projects   Funding   Techniques   Publications  Staff

Funding

“Exploitation of a novel host cell-based drug screen and natural product libraries for lead compound identification with anti-mycobacterial activity“– TTU TB, German Center for Infection Research (DZIF), BMBF (2016-2020)

“Validation of the γ-glutamylpolyamine synthetase GlnA3Mt as a promising target for development of novel anti-tubercular drugs (GPS-TBT)“ – BMBF, Program: Targetvalidation for pharmaceutical  drug development  (2018-2020)

“Clade specific virulence patterns of M. tuberculosis complex strains in human macrophages - Molecular mechanisms underlying phagosomal escape and induction of cell death”- Deutsche Forschungsgemeinschaft (DFG), Priority Program SPP1580 (2012-2018)

“Isolation and Characterization of M. tuberculosis-induced lipid droplets from human primary macrophages“; Leibniz Center Infection (LCI) (2018-2021)